iSITE: Investigation of Somatic Alterations in Tumours of the Eye

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

February 7, 2022

Study Completion Date

February 28, 2025

Conditions
Somatic MutationOcular Melanoma
Interventions
OTHER

sample collection

sample collection of surplus samples not needed for diagnostic or pathological requirements

OTHER

Discussing study/seeking consent

An NHS or CRN staff member will inform patients of the nature and objectives of the study, go through the participant information sheet, highlighting possible risks associated with their participation and reiterate the voluntary nature of this study. Patients will be given opportunities to ask questions pertaining to the study. If the potential participant is still interested in taking part, written informed consent for the study will then be received and a copy of the informed consent will be given to the participant to keep.

OTHER

Completion of Study Questionnaire

Patient will complete in own time. To take place in a routine outpatient clinic appointment

OTHER

Blood Sample

To take place in an outpatient clinic.

Trial Locations (1)

Unknown

Wellcome Sanger Institute, Cambridge

All Listed Sponsors
collaborator

Moorfields Eye Hospital NHS Foundation Trust

OTHER

collaborator

St. Bartholomew's Hospital

OTHER

lead

The Wellcome Sanger Institute

OTHER

NCT06861647 - iSITE: Investigation of Somatic Alterations in Tumours of the Eye | Biotech Hunter | Biotech Hunter